{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:34:48Z","timestamp":1790710488821,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2018,6,5]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">Little is known about the association of atrial fibrillation symptom burden with quality of life and outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              In the Prevention of Thromboembolic Events\u2013European Registry in Atrial Fibrillation (n=6196 patients with atrial fibrillation; mean\u00b1SD age, 71.8\u00b110.4\u00a0years; 39.7% women), we assessed European Heart Rhythm Association score symptoms and calculated correlations with the standardized health status questionnaire (\n              <jats:styled-content style=\"fixed-case\">EQ<\/jats:styled-content>\n              \u20105D\u20105L). Patients were followed up for atrial fibrillation therapies and outcomes (stroke\/transient ischemic attack\/arterial thromboembolism, coronary events, heart failure, and major bleeding) over 1\u00a0year. Most individuals (92%) experienced symptoms. Correlations with health status and quality of life were modest. In multivariable\u2010adjusted regression models, the dichotomized European Heart Rhythm Association score (intermediate\/frequent versus never\/occasional symptoms) was associated with cardioversions (odds ratio [\n              <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n              ], 1.21; 95% confidence interval [\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              ], 1.01\u20131.45) and catheter ablation (\n              <jats:styled-content style=\"fixed-case\">OR,<\/jats:styled-content>\n              1.97; 95%\n              <jats:styled-content style=\"fixed-case\">CI,<\/jats:styled-content>\n              1.44\u20132.69), and inversely related with heart rate control (\n              <jats:styled-content style=\"fixed-case\">OR,<\/jats:styled-content>\n              0.80; 95%\n              <jats:styled-content style=\"fixed-case\">CI,<\/jats:styled-content>\n              0.70\u20130.92) and heart failure incidence (\n              <jats:styled-content style=\"fixed-case\">OR,<\/jats:styled-content>\n              1.65; 95%\n              <jats:styled-content style=\"fixed-case\">CI,<\/jats:styled-content>\n              1.16\u20132.34). Anxiety was inversely related with stroke\/transient ischemic attack\/arterial thromboembolism (\n              <jats:styled-content style=\"fixed-case\">OR,<\/jats:styled-content>\n              0.55; 95%\n              <jats:styled-content style=\"fixed-case\">CI,<\/jats:styled-content>\n              0.32\u20130.93), whereas chest pain related positively with coronary events (\n              <jats:styled-content style=\"fixed-case\">OR,<\/jats:styled-content>\n              2.45; 95%\n              <jats:styled-content style=\"fixed-case\">CI,<\/jats:styled-content>\n              1.42\u20134.22). Fatigue (\n              <jats:styled-content style=\"fixed-case\">OR,<\/jats:styled-content>\n              1.84; 95%\n              <jats:styled-content style=\"fixed-case\">CI,<\/jats:styled-content>\n              1.30\u20132.60), dyspnea (\n              <jats:styled-content style=\"fixed-case\">OR,<\/jats:styled-content>\n              2.33; 95%\n              <jats:styled-content style=\"fixed-case\">CI,<\/jats:styled-content>\n              1.63\u20133.33), and anxiety (\n              <jats:styled-content style=\"fixed-case\">OR,<\/jats:styled-content>\n              1.72; 95%\n              <jats:styled-content style=\"fixed-case\">CI,<\/jats:styled-content>\n              1.16\u20132.55) were associated with heart failure incidence. Palpitations were positively associated with cardioversion (\n              <jats:styled-content style=\"fixed-case\">OR,<\/jats:styled-content>\n              1.32; 95%\n              <jats:styled-content style=\"fixed-case\">CI,<\/jats:styled-content>\n              1.08\u20131.61) and ablation therapy (\n              <jats:styled-content style=\"fixed-case\">OR,<\/jats:styled-content>\n              2.02; 95%\n              <jats:styled-content style=\"fixed-case\">CI,<\/jats:styled-content>\n              1.48\u20132.76).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">A higher symptom burden, in particular palpitations, predicted interventions to restore sinus rhythm. The score itself had limited predictive value, but its individual components were related to different and specific clinical events, and may thus be helpful to target patient management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.117.007559","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T09:15:18Z","timestamp":1526634918000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":43,"title":["Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe"],"prefix":"10.1161","volume":"7","author":[{"given":"Renate B.","family":"Schnabel","sequence":"first","affiliation":[{"name":"University Heart Center Hamburg Eppendorf, Hamburg, Germany"},{"name":"German Center for Cardiovascular Research partner site, Hamburg\/Kiel\/L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Pecen","sequence":"additional","affiliation":[{"name":"Medical Faculty Pilsen of Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nargiz","family":"Rzayeva","sequence":"additional","affiliation":[{"name":"University Heart Center Hamburg Eppendorf, Hamburg, Germany"},{"name":"German Center for Cardiovascular Research partner site, Hamburg\/Kiel\/L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Lucerna","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Europe, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanish","family":"Purmah","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom"},{"name":"Sandwell and West Birmingham Hospitals (SWBH) and University Hospitals Birmingham (UHB) NHS Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco M.","family":"Ojeda","sequence":"additional","affiliation":[{"name":"University Heart Center Hamburg Eppendorf, Hamburg, Germany"},{"name":"German Center for Cardiovascular Research partner site, Hamburg\/Kiel\/L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[{"name":"G. d'Annunzio University, Chieti, Italy"},{"name":"Fondazione G. Monasterio, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom"},{"name":"Sandwell and West Birmingham Hospitals (SWBH) and University Hospitals Birmingham (UHB) NHS Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005119"},{"key":"e_1_3_6_3_2","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.hrthm.2004.03.070","article-title":"Overview of endpoints in atrial fibrillation studies","volume":"1","author":"Wyse DG","year":"2004","unstructured":"Wyse DG. Overview of endpoints in atrial fibrillation studies. Heart Rhythm. 2004;1(suppl):B3\u2013B7, discussion B7.","journal-title":"Heart Rhythm"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eum191"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut395"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.11.026"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.114.001303"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut263"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-012-0322-4"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-7-30"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853890109002087"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euw295"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw285"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.5603\/KP.a2015.0160"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2008.068908"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.08.011"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.06.032"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105575"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.03.016"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euu151"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.05.041"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euv390"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.117.007559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:58:07Z","timestamp":1715597887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.117.007559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,6,5]]}},"alternative-id":["10.1161\/JAHA.117.007559"],"URL":"https:\/\/doi.org\/10.1161\/jaha.117.007559","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"2018-01-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e007559"}}